Regeneron Pharmaceuticals, Inc.

NasdaqGS:REGN Stock Report

Market Cap: US$103.6b

Regeneron Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:REGN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Feb 24SellUS$990,000Joseph LaRosaIndividual1,000US$990.00
22 Feb 24SellUS$967,650Joseph LaRosaIndividual1,000US$967.65
14 Feb 24SellUS$9,831,727Daniel Van PlewIndividual10,434US$951.77
09 Feb 24SellUS$4,689,320Christopher FenimoreIndividual4,919US$955.00
07 Feb 24SellUS$7,637,954Neil StahlIndividual8,037US$953.00
07 Feb 24SellUS$950,000Joseph LaRosaIndividual1,000US$950.00
05 Feb 24SellUS$934,710Marion McCourtIndividual1,000US$934.71
23 Aug 23SellUS$188,212Robert LandryIndividual223US$844.00

Insider Trading Volume

Insider Buying: REGN insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of REGN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies19,5810.0182%
State or Government125,6380.117%
Individual Insiders4,515,3264.2%
General Public9,469,7718.81%
Institutions93,331,58086.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 64.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.3%
FMR LLC
9,996,485US$9.6b4.83%0.64%
8.22%
The Vanguard Group, Inc.
8,838,285US$8.5b0.45%0.14%
8.07%
Capital Research and Management Company
8,668,198US$8.4b-0.56%0.43%
8.03%
BlackRock, Inc.
8,629,707US$8.3b-2.77%0.15%
5.92%
JP Morgan Asset Management
6,365,135US$6.1b-2.69%0.77%
4.56%
State Street Global Advisors, Inc.
4,901,251US$4.7b1.49%0.2%
2.25%
Leonard Schleifer
2,421,895US$2.3b0.51%no data
2.2%
Dodge & Cox
2,367,680US$2.3b-0.22%1.05%
2.19%
Geode Capital Management, LLC
2,354,217US$2.3b1.48%0.19%
1.22%
George Yancopoulos
1,309,728US$1.3b2.53%no data
1.13%
Loomis Sayles & Company, L.P.
1,219,067US$1.2b-1.12%1.62%
1.13%
Putnam LLC
1,210,735US$1.2b2.05%1.33%
1.03%
Wellington Management Group LLP
1,102,090US$1.1b-26.9%0.16%
0.99%
Norges Bank Investment Management
1,061,803US$1.0b9.86%0.09%
0.97%
Northern Trust Global Investments
1,046,408US$1.0b-1.95%0.16%
0.92%
Legal & General Investment Management Limited
985,540US$950.5m20.2%0.2%
0.88%
BNY Mellon Asset Management
941,233US$907.8m-1.88%0.17%
0.87%
American Century Investment Management Inc
931,328US$898.2m1.59%0.5%
0.86%
Amundi Asset Management SAS
919,309US$886.6m33.4%0.2%
0.75%
UBS Asset Management AG
801,318US$772.9m0.19%0.11%
0.69%
AllianceBernstein L.P.
744,217US$717.8m7.51%0.23%
0.67%
T. Rowe Price Group, Inc.
718,052US$692.5m-67.6%0.06%
0.6%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
648,689US$625.6m8.91%0.19%
0.59%
Morgan Stanley, Investment Banking and Brokerage Investments
629,690US$607.3m33.9%0.08%
0.58%
Charles Schwab Investment Management, Inc.
620,616US$598.6m3.77%0.11%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.